Feasibility analysis of the recombinant human thrombomodulin (rTM) for disseminated intravascular coagulation in the perioperative period of Hepato-Biliary-Pancreatic Surgery
Not Applicable
- Conditions
- Possibly operative cases of Hepato-Biliary-Pancreatic tumor
- Registration Number
- JPRN-UMIN000009983
- Lead Sponsor
- Tohoku University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
1. severe bleeding (intracranial bleeding, GI bleeding, Lung bleeding) 2. Patients are likely to cause life-threatening bleeding 3. Patients with a history of cerebrovascular bleeding within one year of 4. not long after the surgery of the central nervous system and trauma 5. Patients with a history of hypersensitivity to heparin or unfractionated protein preparation 6.Pregnant or supposed to be pregnant patient 7. Early death is estimated as well as restored the DIC, the patient seems to be difficult to obtain the data and ensure the efficacy and safety of the investigational drug administration period sufficient 8. Patients were deemed inappropriate investigator
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method safety of the recombinant human thrombomodulin (rTM) for DIC after Hepato-Biliary-Pancreatic surgery
- Secondary Outcome Measures
Name Time Method iver failure(ISGLS) bleeding transfusion recovery rate of DIC SOFA